ACT Advisors »

Heron Therapeutics shares owned by ACT Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by ACT Advisors from 13F filings

Historical chart of ACT Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by ACT Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by ACT Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $61k 22k 2.77
2023-12-31 $38k 22k 1.70

More positions owned by ACT Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Invesco Exch Traded Fd Tr Ii Pfd Etf (PGX)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Indexiq Active Etf Tr Iq Mackay Insred (MMIN)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Ser Tr Portfolio S&p500 (SPLG)
J P Morgan Exchange Traded F Betabuilders Us (BBAG)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for ACT Advisors

Top funds holding Heron Therapeutics

Vanguard Group
Franklin Resources
Clearline Capital
OrbiMed Advisors
Tejara Capital
Palisade Capital Management
JW Asset Management
Orchard Capital Managment
Monaco Asset Management SAM
Tang Capital Management
Congress Park Capital
D. E. Shaw & Co
Millennium Management
New York State Common Retirement Fund
Charles Schwab Investment Management

View all funds holding Heron Therapeutics